Immunomax powder for preparing injection solution, 3-piece vials
Condition: New product
994 Items
Rating:
Be the first to write a review!
More info
Active ingredients
Sour peptidoglycan
Release form
Powder
Composition
Active ingredient: Acidic peptidoglycan with a molecular weight of 1000-40000 c. The concentration of the active substance (one): 200 U
Pharmacological effect
The immunopharmacological mechanisms of the drug's action consist in the fact that it activates the following parts of the immune defense: - NK cells, which 2-3 hours after exposure to the drug, strongly express the activation molecules CD69; the cytolytic activity of NK cells increases by 3 times; - circulating monocytes 2-4 hours after drug activation begin to secrete cytokines: interleukin-8, interleukin-1 beta and tumor necrosis factor alpha; - neutrophil granulocytes are activated due to the activation of monocytes, direct action the drug has no effect on neutrophilic granulocytes; interleukin-8 secreted by monocytes causes activation of neutrophilic granulocytes, which clearly manifests itself 24 hours after exposure to the drug - tissue macrophages, which manifests itself in changing the morphology of these cells, enhancing the production of bactericidal substances, changing the activity of 5'-nucleotidase; , soluble and corpuscular. Strengthens protection against infections caused by viruses (human papilloma virus, herpes simplex virus, parvovirus, plague carnivorous virus, etc.) and whether bacteria (E. coli, salmonella, staphylococcus, chlamydia, mycoplasma, ureaplasma and others). This effect is manifested in adults and newborns with the introduction of the drug in various ways: intramuscularly, intravenously, intraperitoneally, inside.
Indications
The drug is used in the treatment of diseases associated with secondary immunodeficiency states: - acute respiratory diseases, inflammatory diseases of the oropharynx of bacterial and viral etiology in children and adults - acute viral (rotavirus) and bacterial (salmonella, dysentery, coli infection) intestinal infections, including manifestations of intestinal dysbiosis of varying severity in children - urogenital chlamydia in women (including pregnant women in the second and third trimesters of pregnancy), including manifestations of vaginal dysbiosis, vulvovaginitis, cervicitis of the uterus, cervical erosion.
Contraindications
Hypersensitivity to the drug; children's age up to 12 years.
Use during pregnancy and lactation
No data are available on the effects of the drug on pregnant women. As in the case of other drugs, should not be used during pregnancy, unless the benefits to the patient do not exceed the possible risk to the fetus. Not recommended for nursing mothers.
Dosage and administration
V / m The recommended dose for adults and children over 12 years old is 100–200 IU once a day. Before use, the contents of the ampoule are dissolved in 1 ml of water for injection, injected into / m 100-200 U, depending on the severity of the disease. The course of treatment is 6 injections in 1, 2, 3, 8, 9, 10 days of treatment. Treatment of recurrent anogenital warts: a course of 6 injections of 200 IU combined with the destruction of warts by one of the common methods: cryodestruction, electrocoagulation, laser destruction or appointment of solcoderm . Treatment of infections caused by bacteria or viruses: a course of 6 injections of 100-200 units. Correction of a weakened immunity: a course of 3–6 injections of 100–200 U.
Side effects
Not detected.
Interaction with other drugs
Not described.